7-5064030-G-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_021163.4(RBAK):​c.574G>A​(p.Glu192Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,460,940 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000027 ( 0 hom. )

Consequence

RBAK
NM_021163.4 missense

Scores

18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.408
Variant links:
Genes affected
RBAK (HGNC:17680): (RB associated KRAB zinc finger) This gene encodes a nuclear protein which interacts with the tumor suppressor retinoblastoma 1. The two interacting proteins are thought to act as a transcriptional repressor for promoters which are activated by the E2F1 transcription factor. This protein contains a Kruppel-associated box (KRAB), which is a transcriptional repressor motif. Read-through transcripts that include exons from the downstream gene LOC389458 are expressed from this locus. [provided by RefSeq, Mar 2011]
RBAK-RBAKDN (HGNC:42971): (RBAK-RBAKDN readthrough) This locus represents naturally occurring read-through transcription between the neighboring RBAK (RB-associated KRAB zinc finger) and LOC389458 (hypothetical LOC389458) genes on chromosome 7. The read-through transcript encodes a protein that shares sequence identity with the upstream gene product but its C-terminal region is distinct due to frameshifts relative to the downstream gene. [provided by RefSeq, Mar 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.114108175).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RBAKNM_021163.4 linkc.574G>A p.Glu192Lys missense_variant 5/5 ENST00000396912.2 NP_066986.1 Q9NYW8-1
RBAKNM_001204456.2 linkc.574G>A p.Glu192Lys missense_variant 6/6 NP_001191385.1 Q9NYW8-1
RBAK-RBAKDNNM_001204513.3 linkc.238+6251G>A intron_variant NP_001191442.1 A0A0A6YYG8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RBAKENST00000396912.2 linkc.574G>A p.Glu192Lys missense_variant 5/51 NM_021163.4 ENSP00000380120.1 Q9NYW8-1
RBAK-RBAKDNENST00000407184.5 linkc.299+275G>A intron_variant 2 ENSP00000385560.1 I3L0D1
RBAKENST00000353796.7 linkc.574G>A p.Glu192Lys missense_variant 6/62 ENSP00000275423.4 Q9NYW8-1
RBAK-RBAKDNENST00000396904.2 linkc.238+6251G>A intron_variant 4 ENSP00000380112.2 A0A0A6YYG8

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.0000200
AC:
5
AN:
249384
Hom.:
0
AF XY:
0.0000222
AC XY:
3
AN XY:
134970
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000272
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000274
AC:
4
AN:
1460940
Hom.:
0
Cov.:
31
AF XY:
0.00000275
AC XY:
2
AN XY:
726744
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000101
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32
Bravo
AF:
0.0000113
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 01, 2024The c.574G>A (p.E192K) alteration is located in exon 5 (coding exon 4) of the RBAK gene. This alteration results from a G to A substitution at nucleotide position 574, causing the glutamic acid (E) at amino acid position 192 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
16
DANN
Benign
0.78
DEOGEN2
Benign
0.036
T;T
Eigen
Benign
-0.34
Eigen_PC
Benign
-0.42
FATHMM_MKL
Benign
0.00098
N
LIST_S2
Benign
0.077
.;T
M_CAP
Benign
0.0029
T
MetaRNN
Benign
0.11
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.36
N;N
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-1.0
N;N
REVEL
Benign
0.14
Sift
Benign
0.16
T;T
Sift4G
Benign
0.64
T;T
Polyphen
0.82
P;P
Vest4
0.39
MutPred
0.56
Gain of ubiquitination at E192 (P = 0.0117);Gain of ubiquitination at E192 (P = 0.0117);
MVP
0.33
MPC
0.35
ClinPred
0.16
T
GERP RS
3.8
Varity_R
0.091
gMVP
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs765590837; hg19: chr7-5103661; COSMIC: COSV62332492; COSMIC: COSV62332492; API